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1. Glossary of Terms: Vision Screening 
Abnormal test result A test result where ĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
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1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
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Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2. Abbreviations 
GDP  Gross Domestic Product 
GP General Practitioner 
NICU  Neonatal-intensive care unit 
PPP  Purchasing Power Parity 
ROP Retinopathy of Prematurity 
VA  Visual Acuity  
WHO  World Health Organisation  
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3. Population and Healthcare Overview 
The population of Luxembourg is 599,449 (World Bank, 2018a) and the birth rate was 
estimated at 10.4 births/1,000 population in 2016 (World Bank, 2018b). The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively. 
Luxembourg had an estimated population density of 232 people per square kilometre in 
2017 and this has risen from 169 people per square kilometre in 1961 (World Bank, 2018c). 
In terms of healthcare facilities, the total density of hospitals in 2013 was 1.13 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 2.1 deaths/1,000 live 
births in total (World Bank, 2018d). 
The average life expectancy in Luxembourg is estimated at 82.3 years (World Bank, 2018e), 
with a death rate of 6.8 deaths/1,000 population in 2016 (World Bank, 2018f). Luxembourg 
has a gross national income per capita (PPP int. $, 2013) of $59,750 (WHO, 2016b). The 
estimated total expenditure on health per capita in 2014 was $6,812 (Intl $) and the total 
expenditure on health in 2014 as percentage of GDP was 6.9% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Luxembourg between 1960 and 2016/2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
Vision screening is organised nationally with no regional variation in protocols. It is funded 
by the state. It is not embedded into a general preventative child healthcare system. The 
content of the vision screening programme is decided upon by the Health Directorate, 
Orthoptic Service. Vision screening was implemented for pre-school children in 1969 and for 
infants in 1971.  
Review of the vision screening programme, how revisions are funded and how and when 
they take place is not defined. Since its implementation, the vision screening programme 
has changed in terms of the ages that screening takes place and the use of an autorefractor. 
The date for these changes is not known.  
In Luxembourg, vision screening takes place at the headquarter of the Orthoptic Service and 
in 7 other locations rented by the Orthoptic Service, including kindergartens, public schools 
and schools. The professionals that perform vision screening are orthoptists and nurses. 
However, there are only nine orthoptists active in the screening programme. No other 
general professionals have been identified that do not screen, but could do so with 
additional training. There is no organised, specific training in order to perform vision 
screening.  
There are no methods for quality monitoring for vision screening set-out by the 
government. No research concerning the vision screening programme in Luxembourg has 
been identified. There has been no cost-effectiveness analysis, or any other studies on the 
effectiveness of vision screening programme. 
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5 Screening programme  
The target conditions screened for by vision screening include retinopathy of prematurity 
(ROP), amblyopia, reduced visual acuity, refractive error, colour vision defects, manifest and 
leatent strabismus, and anisocoria. The health care professionals delivering vision screening, 
venue for screening and tests used vary depending on the age of the child as shown in 
Tables 1, 2 and 3 respectively. Specific details of the screening offered within each age 
group are described more fully in sections 5.1 to 5.4 below.  
5.1 Vision screening ʹ Preterm babies 
Preterm babies are checked by an ophthalmologist during their stay in the hospital if risk 
factors due to prematurity are fulfilled. These factors are not known. The child is referred 
for further diagnostic examination when any pathology is apparent. 
5.2 Vision screening - Birth to 3 months 
The tests conducted on well, healthy babies up to the age of 3 months include Hirschberg 
and pupillary reflexes. These tests are performed by a paediatrician in either a hospital or a 
ĚŽĐƚŽƌ ?ƐŽĨĨŝĐĞĚƵƌŝŶŐ ?ĨŝƌƐƚŐĞŶĞƌĂůŚĞĂůƚŚĐŚĞĐŬ-ups; less than 48 hours after birth, at age 
1to10 days and 3to 8 weeks. The check-ups are mandatory. The child is referred for further 
diagnostic examination when any pathology is apparent. 
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened at 10 months of age by an orthoptist at a 
governmental department. The tests used at this age include ocular motility assessment, 
Hirschberg test, cover test, alternating cover test, stereopsis using the Lang 1 Test and 
autorefraction using PlusOptix (10 months-48 months). The referral criteria at this age 
category is not known. 
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened three times by an orthoptist at either a 
governmental department within the orthoptic service at 36 months to 4 years of age or 
school from 4 years to 6 years of age. The screening takes place at 36 months, 5 to 5 years 
of age and 5 to 6 years of age.  The tests used within this age group include ocular motility 
assessment, Hirschberg test, cover test, alternating cover test, visual acuity measurement, 
stereopsis using the Lang 1 Test, colour vision, automated screening (PlusOptix at 36 
months to 4 years of age). Visual acuity is measured for the first time at 36 months using the 
Rossano-Weiss, Tumbling E and Multivisus (computerised) optotype charts. These are all 
linear uncrowded tests.  
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If a child is not screened for visual acuity at 36 months, they are tested at 48 months by an 
orthoptist at governmental departments. The visual acuity measurement is repeated at ages 
4 to 5 years and 5to 6 years.  
At 36 months, the referral criteria is hyperopia, astigmatism or anisometropia over 1.5 
diopters, strabismus, heterophoria, exophthalmia, a difference in reflexes on the 
autorefractor, or visual acuity different in both eyes of less than 0.6 decimal (0.2 logMAR, 
6/9.5 Snellen). I 
At 48 months, the referral criteria is hyperopia, astigmatism or anisometropia over 1.5 
diopters, strabismus, heterophoria, exophthalmia, negative stereopsis, or visual acuity of 
less than 0.8 decimal (0.1 logMAR, 6/7.5 Snellen)).  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Paediatrician Ophthalmologist Nurses Orthoptist 
Preterm babies  
 
9 
In certain cases 
 
9 
In certain cases 
× × 
0 to 3 months  
 
9 × × × 
3 to 36 months  × × × 
 
9 
3 to 7 years  × × × 
 
9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
motility 
Hirschberg Pupillary 
reflexes 
Cover test Alternating 
cover test 
Visual acuity 
measurement 
Stereopsis Colour 
vision 
Automated 
screening 
Preterm babies  
No 
protocol 
 
No  
protocol 
 
No 
protocol 
 
No 
protocol 
 
No  
protocol 
 
No       
protocol 
 
No 
protocol 
 
No  
protocol 
 
No  
protocol 
 
0 to 3 months  × 
 
9 
 
9 × × × × × × 
3 to 36 months  
 
9 
 
9 × 
 
9 
 
9 × 
 
9 × 
 
9 
3 to 7 years  
 
9 
 
9 × 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
Only up to 
48 months 
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Table 3: Location of vision screening for each age group  
Table 3 
Hospital ŽĐƚŽƌ ?ƐŽĨĨŝĐĞ School Governmental 
Department 
Preterm babies  
 
9 × × × 
0 to 3 months  
 
9 
 
9 × × 
3 to 36 months  × × × 
 
9 
3 to 7 years  × × 
 
9 
 
9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss.  
Automated refraction screening is used in the context of vision screening in combination 
with other tests on all children between 10-48 months. These tests are eye motility, 
Hirschberg test, cover test, alternating cover test, visual acuity measurement, stereopsis and 
colour vision.  
If a child is screened at 36 months, the referral criteria from the automated screening is 
hyperopia, astigmatism or anisometropia over 1.5 dioptres. 
If a child is screened at 48 months, the referral criteria is hyperopia, astigmatism or 
anisometropia over 1.5 dioptres).  
In Luxembourg, PlusOptix is used  ? with each device costing 7,800 Euros. There is no specific 
timescale on when the devices are scheduled to be replaced.  
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7 Provision for Visually Impaired  
There is one school in Luxembourg for blind or severely visually impaired children. The 
number of students is 141. The costs per child for this school is not known and it is not 
known what special support is offered to visually impaired children who attend mainstream 
primary school.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated, persistent (missed by screening or failed treatment) or untreated 
amblyopia by the age of 7 years in Luxembourg is unknown. The prevalence of strabismus is 
reported by the country representative as 1.6% at the age of 4 to 6 years. There is no data 
available concerning the incidence of the four types of amblyopia (strabismic, refractive, 
combined mechanism and deprivation). 
8.2 Coverage 
Ninety-nine percent of children aged 10 months are invited for vision screening. Sixty 
percent of these children attend the appointments. The rate of attendance is 70% for the all 
children aged between 10 and 48 months. Children are referred after 1 or 2 abnormal or 
inconclusive test results; this is determined by the screener. All children aged 4 and 5 years, 
are invited for the screening in schools. 
8.3 Screening evaluation 
There is no information pertaining to the percentage of compliance with referral after an 
abnormal screening test result, as there is no registration or documentation of non-
attendance. There is no information concerning the percentage of false negative following 
vision screening. The percentage of false positive referrals for vision screening is estimated 
at 10%, with a positive predictive value of a refer estimated at 80%. There is no data 
available about the sensitivity or specificity of vision screening in Luxembourg.  
8.4 Treatment success 
There is no data regarding: 
x the percentage of infants treated per year for congenital eye disorders (including 
congenital cataract) 
x the percentage of screened children treated for strabismus or amblyopia before age 
7 years 
x the percentage of all children treated for strabismus or amblyopia before age 7 
years  
The percentage of all children treated for amblyopia at the ages of 4 to 6 years is reported 
as 0.4%. The percentage of children aged 5 to 6 years wearing glasses is reported as 13.4%.  
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Only ophthalmologists prescribe glasses for children under the age of 14 years. Other 
treatment options may include patching, penalisation with glasses and cataract surgery 
when indicated. All eligible children are offered treatment.   
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
Vision screening professionals in Luxembourg are estimated to earn an annual salary of 
50,000 Euros. The salary costs per hour are not known. It is not known how much it costs to 
train general preventative child health care screening professionals, between leaving 
secondary education to qualification. It is not known the total screening costs per year for 
vision screening are, or what the total costs per child per year for vision screening are, 
nationally.  
9.2 Cost of treatment for amblyopia 
The estimated costs of treatment for typical patients with refractive amblyopia and 
strabismic amblyopia, including follow-up, are not known. 
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery, including follow-up, are not known.  
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, including follow-up of deprivation 
amblyopia, are not known. 
There is a financial reward of 580 Euros if the child takes part in 6 general check-ups at the 
paediatrician: the first one has to take place within 48 hours after birth. The other five have 
to take place at ages: 1 to 10 days, 4 to 6 months, 9 to 12 months, and 21 to 24 months. 
There is no penalty for non-attendance. Vision screening is not obligatory in Luxembourg.  
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